Racura Oncology Ltd (ASX:RAC)
2.460
0.00 (0.00%)
At close: Mar 6, 2026
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 446.99 million as of March 6, 2026. Its market cap has increased by 116.22% in one year.
Market Cap
446.99M
Enterprise Value
426.04M
Revenue
3.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.46
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 446.99M, an increase of 3,437.06%. That is a compound annual growth rate of 44.69%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 509.04M |
| Immutep | 560.01M |
| Opthea | 738.77M |
| Dimerix | 246.16M |
| Orthocell | 242.82M |
| Tetratherix | 201.54M |
| Starpharma Holdings | 165.87M |
| Clarity Pharmaceuticals | 1.29B |